Related Experiment Video
Updated: Jun 10, 2026
Accessing Early Differentiation of Virus-Specific Follicular Helper CD4+ T Cell in Acute LCMV-Infected Mice
Published on: April 26, 2024
Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1
John P Graham1, Kelly M Arcipowski, Gail A Bishop
1Interdisciplinary Graduate Program in Immunology, The University of Iowa, Iowa City, IA 52242, USA.
Insights
CD40 is crucial for immune responses, but Epstein-Barr virus protein LMP1 mimics it abnormally. Comparing CD40 and LMP1 reveals insights into B-cell activation and disease, aiding therapeutic development.
Area of Science:
- Immunology
- Molecular Biology
- Virology
Background:
- CD40 is a key receptor in humoral immunity, particularly activating B lymphocytes.
- Epstein-Barr virus (EBV) protein LMP1 mimics CD40 signaling in B cells.
- LMP1 lacks regulatory controls, leading to aberrant B-cell activation.
Purpose of the Study:
- To comparatively analyze the functions and mechanisms of CD40 and LMP1 in B lymphocytes.
- To understand how CD40 signaling is normally regulated.
- To elucidate how LMP1 disrupts normal CD40 pathways for therapeutic insights.
Main Methods:
- Comparative analysis of CD40 and LMP1 functions.
- Review of molecular mechanisms governing CD40 and LMP1 signaling pathways.
- Examination of the role of these interactions in B-cell lymphoma and autoimmune diseases.
Main Results:
- LMP1 acts as a functional mimic of CD40 but bypasses critical regulatory checkpoints.
- Aberrant B-cell activation by LMP1 contributes to pathogenesis.
- Understanding these differences provides a framework for CD40 pathway regulation.
Conclusions:
- Comparative analysis of CD40 and LMP1 offers valuable insights into normal CD40 signaling regulation.
- Disruption of CD40 pathways by LMP1 highlights potential therapeutic targets.
- This knowledge can inform the design of novel therapies for B-cell malignancies and autoimmune disorders.
Abstract:
CD40 plays a vital role in humoral immunity, via its potent and multifaceted function as an activating receptor of various immune cells, most notably B lymphocytes. The Epstein-Barr virus-encoded transforming protein latent membrane protein 1 (LMP1) serves as a functional mimic of CD40 signals to B cells but lacks key regulatory controls that restrain CD40 signaling. This allows LMP1 to activate B cells in an abnormal manner that can contribute to the pathogenesis of human B-cell lymphoma and autoimmune disease. This review focuses upon a comparative analysis of CD40 versus LMP1 functions and mechanisms of action in B lymphocytes, discussing how this comparison can provide valuable information on both how CD40 signaling is normally regulated and how LMP1 disrupts the normal CD40 pathways, which can provide information of value to therapeutic design.
Related Concept Videos
01:22T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
01:24B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...